Does MUROMONAB-CD3 Cause Vitreous floaters? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Vitreous floaters have been filed in association with MUROMONAB-CD3. This represents 6.1% of all adverse event reports for MUROMONAB-CD3.
7
Reports of Vitreous floaters with MUROMONAB-CD3
6.1%
of all MUROMONAB-CD3 reports
0
Deaths
0
Hospitalizations
How Dangerous Is Vitreous floaters From MUROMONAB-CD3?
Of the 7 reports.
Is Vitreous floaters Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MUROMONAB-CD3. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does MUROMONAB-CD3 Cause?
Post transplant lymphoproliferative disorder (22)
Infection (16)
Cytomegalovirus infection (13)
Cytomegalovirus oesophagitis (10)
Drug resistance (10)
Duodenitis (10)
Gastritis (10)
Weight decreased (10)
Chest pain (9)
Cytomegalovirus chorioretinitis (9)
What Other Drugs Cause Vitreous floaters?
AFLIBERCEPT (690)
BROLUCIZUMAB-DBLL (479)
RANIBIZUMAB (458)
BEVACIZUMAB (323)
ADALIMUMAB (300)
DUPILUMAB (300)
CIPROFLOXACIN (189)
FINGOLIMOD (129)
FARICIMAB\FARICIMAB-SVOA (123)
UPADACITINIB (112)
Which MUROMONAB-CD3 Alternatives Have Lower Vitreous floaters Risk?
MUROMONAB-CD3 vs MYCOPHENOLATE
MUROMONAB-CD3 vs MYCOPHENOLATE MOFETIL
MUROMONAB-CD3 vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MUROMONAB-CD3 vs MYCOPHENOLIC ACID
MUROMONAB-CD3 vs MYFORTIC